Uremic Encephalopathy Management

Diagnosis and Assessment

• The American Society of Nephrology recommends that incoherent speech with elevated creatinine indicates uremic encephalopathy, a neurological complication of severe renal dysfunction characterized by altered mental status, confusion, and speech disturbances 1
• The improving creatinine does NOT exclude uremic encephalopathy—the absolute level remains critically elevated and uremic toxins accumulate faster than creatinine clearance improves 2
• This represents persistent AKI (Stage 3 given the creatinine level >3× normal), which carries significantly worse morbidity and mortality outcomes 1, 2

Immediate Management

• The National Kidney Foundation suggests consulting nephrology IMMEDIATELY for likely renal replacement therapy given uremic encephalopathy, which is an absolute indication for urgent dialysis 3
• Other urgent indications to assess include severe metabolic acidosis, hyperkalemia refractory to medical management, volume overload with pulmonary edema, and pericarditis 3, 4, 5
• The European Renal Association recommends maintaining aggressive hydration with isotonic crystalloids to achieve urine output ≥2 L/day, monitoring closely for volume overload 3

Medication Management

• The American College of Clinical Pharmacy recommends discontinuing ALL nephrotoxic medications: NSAIDs, ACE inhibitors, ARBs, aminoglycosides, vancomycin 3, 4
• The International Society of Nephrology suggests holding diuretics unless volume overload is present 3, 5
• The National Institute of Diabetes and Digestive and Kidney Diseases recommends adjusting ALL medication doses for current GFR (not baseline) 1, 3

Monitoring and Follow-Up

• The American Society of Nephrology recommends daily serum creatinine and urine output monitoring until stabilization 3, 4
• The "stuttering recovery pattern" (fluctuating creatinine) is associated with worse mortality compared to prompt recovery—this patient's trajectory needs close observation 1, 2
• The European Renal Association suggests follow-up renal function at 1-2 weeks post-discharge, then at 3 months to assess for CKD development 3, 4